Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 22 September 2026.
Announcements
2,180
Total raised
£9.5B
disclosed amounts
This month
£21.4M
raised so far
The seed round was supported by High-Tech Gründerfonds, Big Sur Ventures and Fuel Ventures to scale the platform's resource pool.
"We are thrilled to embark on the next chapter of our journey, supported by our incredible investors, partners and IT Specialists. This funding will play a vital role in bridging the skills gaps that many businesses are facing, whilst also spearheading the future of work by creating job opportunities within our community"
The seed round was led by Balderton Capital and will fund product development and team expansion.
"The user experience as an adult learner sucks! Whether we’re learning to solve specific problems at work or trying to modernise our skill sets, learning is inconvenient, impersonal, and high friction. Team Grasp is the A-players fixing that."
The London-based customer engagement platform has raised £3.8m in a Seed round led by Fuel Ventures to expand internationally.
"The challenges that today’s industry faces are complex, and we founded Odore to provide solutions that are not only comprehensive but also transform the way brands strategize, operate, and connect. This is just the beginning. With this latest funding round, we’re delighted to have Fuel Ventures on board for our next chapter as we expand our team and business globally and launch new tools to better serve our customers."
The funding round was led by Octopus Ventures with backing from JamJar and Forward Partners.
"This latest injection of funding – from experienced investors with a proven track record of backing successful fertility and femtech businesses – will enable us to get our pioneering treatment in the hands of the people who need it most. We can’t wait for people to try it."
The London based healthtech startup secured backing from investors including Entrepreneur First and Form Ventures to expand its platform into clinical settings.
"Our technology is revolutionary. By combining cutting edge neuroscience and ethical, explainable AI, we have built a tool that can help people get an accurate diagnosis and effective treatment plan in place faster than ever before. It’s all about arming clinicians with the very best tools so that they can do the very best by their patients. We’re so grateful for the support our investors have shown us so far; and we look forward to this next stage of our journey as we look to optimise and expand our technology and get it in the hands of the people who need it most."
